Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate the pathologic features, complications, and prognostic factors of functioning adrenal adenoma and suggest follow-up algorithms for adrenal incidentaloma.
The investigators will recruit 150 patients annually for 10 years (adrenal incidentaloma 100 patients, pheochromocytoma 15 patients, primary aldosteronism 25 patients, adrenal cushing syndrome 10 patients, adrenocortical carcinoma 2 patients) and perform hormonal, biochemical, imaging exam according to each disease's clinical guidelines. Based on this, the investigators will identify pathologic features, complications, and prognostic factors of each disease.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Non-functioning adrenal incidentaloma | patients who were diagnosed with non-functioning adrenal incidentaloma on computed tomography or magnetic resonance imaging |
| |
| Pheochromocytoma | patients who were diagnosed with pheochromocytoma biochemically or histologically |
| |
| Primary aldosteronism | patients who were diagnosed with primary aldosteronism by saline loading test |
| |
| Adrenal cushing syndrome | patients who were diagnosed with adrenal cushing syndrome by dexamethasone suppression test and 24 urine free cortisol test. |
| |
| Adrenocortical carcinoma | patients who were diagnosed with adrenocortical carcinoma by imaging study or histologic exam |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Hormone study and Imaging study | Other |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of participants in remission | Remission rate | Up to 10 years |
| Measure | Description | Time Frame |
|---|---|---|
| Complication of adrenal disease | all complications including deaths | Up to 10 years |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
study population of this study is the patients who are newly diagnosed with adrenal disease such as adrenal incidentaloma, pheochromocytoma, primary aldosteronism, adrenal cushing syndrome, adrenocortical carcinoma
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jung Hee Kim, M.D | Seoul National University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University Hospital | Seoul | 03080 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000182 | ACTH Syndrome, Ectopic |
| D003480 | Cushing Syndrome |
| D010673 | Pheochromocytoma |
| C538238 | Adrenal incidentaloma |
| D018268 | Adrenocortical Carcinoma |
| D006929 | Hyperaldosteronism |
| ID | Term |
|---|---|
| D009384 | Paraneoplastic Endocrine Syndromes |
| D010257 | Paraneoplastic Syndromes |
| D009369 | Neoplasms |
| D000308 | Adrenocortical Hyperfunction |
Not provided
Not provided
Not provided
Not provided
Not provided
| D000307 | Adrenal Gland Diseases |
| D004700 | Endocrine System Diseases |
| D010235 | Paraganglioma |
| D018358 | Neuroendocrine Tumors |
| D017599 | Neuroectodermal Tumors |
| D009373 | Neoplasms, Germ Cell and Embryonal |
| D009370 | Neoplasms by Histologic Type |
| D009380 | Neoplasms, Nerve Tissue |
| D000230 | Adenocarcinoma |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D000306 | Adrenal Cortex Neoplasms |
| D000310 | Adrenal Gland Neoplasms |
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D000303 | Adrenal Cortex Diseases |